A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar.
Saved in:
| Title: | A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar. |
|---|---|
| Authors: | Stringer F; Takeda Pharmaceutical Company, Osaka, Japan., DeJongh J, Scott G, Danhof M |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2014 Apr; Vol. 54 (4), pp. 453-61. Date of Electronic Publication: 2013 Nov 20. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 24214217 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stringer+F%22">Stringer F</searchLink>; Takeda Pharmaceutical Company, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22DeJongh+J%22">DeJongh J</searchLink><br /><searchLink fieldCode="AU" term="%22Scott+G%22">Scott G</searchLink><br /><searchLink fieldCode="AU" term="%22Danhof+M%22">Danhof M</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2014 Apr; Vol. 54 (4), pp. 453-61. <i>Date of Electronic Publication: </i>2013 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24214217 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/jcph.227 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 453 Titles: – TitleFull: A model-based approach to analyze the influence of UGT2B15 polymorphism driven pharmacokinetic differences on the pharmacodynamic response of the PPAR agonist sipoglitazar. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stringer F – PersonEntity: Name: NameFull: DeJongh J – PersonEntity: Name: NameFull: Scott G – PersonEntity: Name: NameFull: Danhof M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2014 Apr Type: published Y: 2014 Identifiers: – Type: issn-electronic Value: 1552-4604 Numbering: – Type: volume Value: 54 – Type: issue Value: 4 Titles: – TitleFull: Journal of clinical pharmacology Type: main |
| ResultId | 1 |
